Ecolab (ECL)
(Delayed Data from NYSE)
$244.57 USD
-1.16 (-0.47%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $244.55 -0.02 (-0.01%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$244.57 USD
-1.16 (-0.47%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $244.55 -0.02 (-0.01%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth B Momentum C VGM
Zacks News
Royal Gold (RGLD) Issues Stream Segment Sales Update for Q2
by Zacks Equity Research
Royal Gold (RGLD) sells 52,600 gold equivalent ounces in the June-end quarter of 2024.
DuPont (DD) Tyvek Richmond Facility Gets ISCC+ Certification
by Zacks Equity Research
DuPont's (DD) global integration of ISCC PLUS certification into Tyvek production coincides with the company's commitment to empowering clients on their road to net zero emissions.
Stryker (SYK) Gains 11.6% YTD: What's Driving the Stock?
by Zacks Equity Research
Styker's (SYK) flagship Mako Total Knee Platform and a diversified product portfolio raise optimism about the stock.
Here's Why You Should Add H.B. Fuller (FUL) to Your Portfolio
by Zacks Equity Research
H.B. Fuller (FUL) presents a substantial investment opportunity with robust earnings outperformance and promising growth prospects.
ArcelorMittal (MT)-Partners Begin Carbon Capture Trial in Ghent
by Zacks Equity Research
ArcelorMittal (MT), MHI and D-CRBN are trialing plasma technology at Gent to convert CO2 into carbon monoxide for steel and chemical production, aiming to reduce emissions.
BASF (BASFY) Expands Sodium Methylate Capacity in South America
by Zacks Equity Research
This capacity increase is another step in BASF's (BASFY) business expansion for sodium methylate in South America, demonstrating the company's commitment to its customers and the South American biodiesel market.
Yara (YARIY) and Scatec Ink Renewable Ammonia Offtake Deal
by Zacks Equity Research
This project will bolster Yara's (YARIY) renewable ammonia sourcing portfolio and allow it to reliably serve its customers across several markets.
Baxter (BAX) Recovers After Life2000 Ventilation Systems Recall
by Zacks Equity Research
Baxter (BAX) recalls Life2000 ventilators due to damaged battery charger dongles, posing a risk of device failure
Hawkins (HWKN) Strengthens Water Treatment With Wofford Buy
by Zacks Equity Research
Hawkins (HWKN) acquires Wofford Water Service, strengthening its presence in the southern U.S. and expanding its Water Treatment business in Mississippi.
Smith & Nephew's (SNN) 5% Stake Acquired by Cevian Capital
by Zacks Equity Research
Smith & Nephew (SNN) eyes future growth as Cevian Capital purchases a 5% stake in the company.
Sandstorm Gold (SAND) Posts Y/Y Preliminary Q2 Revenue Decline
by Zacks Equity Research
Sandstorm Gold's (SAND) preliminary revenues fall 16.9% year over year, while the cash operating margin improves 17.1% in the second quarter.
Reasons to Retain Fresenius Medical (FMS) in Your Portfolio Now
by Zacks Equity Research
Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
Arkema (ARKAY) Gets ISCC+ for Powder Coating Resins Facility
by Zacks Equity Research
The facility of Arkema (ARKAY) includes a polyester resin production line and a cutting-edge R&D laboratory dedicated to increasing the sustainability and performance of powder coating materials
Three Reasons to Hold BD (BDX) Stock in Your Portfolio Now
by Zacks Equity Research
BD's (BDX) robust product portfolio raises optimism about the stock.
Masimo (MASI) Fights Politan in a Bid to Retain CEO on Board
by Zacks Equity Research
Will Masimo (MASI) lose its CEO in its fight against activist investor Politan Capital Management? The company's management and employees want Joe Kiani to continue as the CEO.
DexCom (DXCM), Abbott to Launch First FDA Cleared OTC CGMs
by Zacks Equity Research
Dexcom (DXCM) and Abbott are set to launch their first FDA-approved over-the-counter CGMs, Stelo and Lingo & Libre Rio, respectively, in the United States this summer.
Microbot Medical (MBOT) Inks Agreement to Begin LIBERTY Trial
by Zacks Equity Research
Microbot Medical's (MBOT) LIBERTY Endovascular Robotic System trial expands to Baptist Hospital of Miami, promising advancements in clinical outcomes and endovascular procedures.
BASF (BASFY) Partners ENGIE for Sustainable Biomethane Supply
by Zacks Equity Research
BASF (BASFY) and ENGIE sign an agreement to supply biomethane to Ludwigshafen and Antwerp sites, supporting sustainable manufacturing and reducing carbon footprints.
Commercial Metals (CMC) Bets on US Demand as Europe Market Ails
by Zacks Equity Research
Commercial Metals (CMC) gains from strong demand in North America for each of its primary product lines. However, market uncertainties in Europe remain a concern for the company.
Steel Dynamics (STLD) Declares Completion of Note Offering
by Zacks Equity Research
This transaction marks an important component of Steel Dynamics' (STLD) long-term plan to establish a solid capital foundation to support its team, customers, shareholders and future growth.
Cardinal Health (CAH) Recalls Kits Containing Shenli's Syringes
by Zacks Equity Research
Cardinal Health (CAH) recalls its procedure kits that contain plastic syringes manufactured by a Chinese manufacturer, Jiangsu Shenli.
Lucid Diagnostics (LUCD) Reports Positive ESOGUARD BE-1 Data
by Zacks Equity Research
Lucid Diagnostic's (LUCD) ESOGUARD BE-1 study data shows high sensitivity and negative predictive value for the EsoGuard test, enhancing early detection of esophageal precancer in a screening population.
Axalta (AXTA) Closes CoverFlexx Buy, Boosts Refinish Coatings
by Zacks Equity Research
Axalta Coating (AXTA) acquires The CoverFlexx Group to enhance its Refinish coatings offerings and support growth in the automotive refinish market.
Barrick's (GOLD) Kibali Mine to Sustain Annual Gold Production
by Zacks Equity Research
Barrick's (GOLD) Kibali mine sustains high production and leads in renewable energy, fostering regional growth and biodiversity.
DOW Announces Launch of Bio-Based NORDEL REN EPDM at DKT 2024
by Zacks Equity Research
NORDEL REN EPDM is set to provide a lower-carbon product by using bio leftovers from other industries as raw material, thus helping DOW customers in the rubber business.